Hyaluronan: Pharmaceutical Characterization and Drug Delivery
暂无分享,去创建一个
Ben Forbes | G. P. Martin | B. Forbes | Y. Liao | Gary P Martin | Marc B Brown | Stuart A. Jones | Yong-Hong Liao | Stuart A Jones | M. Brown | Marc B. Brown
[1] Lilly Y. W. Bourguignon,et al. Signaling Properties of Hyaluronan Receptors* , 2002, The Journal of Biological Chemistry.
[2] K. Kimata,et al. Mammalian Hyaluronan Synthases , 2002, IUBMB life.
[3] B. Toole,et al. Hyaluronan in morphogenesis. , 2001, Journal of internal medicine.
[4] O. Camber,et al. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. , 1989, Current eye research.
[5] L. Sundblad. Chapter 29 – GLYCOSAMINOGLYCANS AND GLYCOPROTEINS IN SYNOVIAL FLUID , 1965 .
[6] Bin Zhou,et al. Identification of the Hyaluronan Receptor for Endocytosis (HARE)* , 2000, The Journal of Biological Chemistry.
[7] T. Yamaguchi,et al. Molecular weight independence of the effect of additive hyaluronic acid on the lubricating characteristics in synovial joints with experimental deterioration. , 1999, Clinical biomechanics.
[8] Jennifer G. Smith,et al. Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses , 1997, The Australasian journal of dermatology.
[9] A. J. Day,et al. Hyaluronan-binding Proteins: Tying Up the Giant* , 2002, The Journal of Biological Chemistry.
[10] M. Jassal,et al. Use of polysaccharide fibres for modern wound dressings , 2002 .
[11] S. Gandolfi,et al. Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[12] T. Laurent,et al. Fractionation of hyaluronic acid. The polydispersity of hyaluronic acid from the bovine vitreous body. , 1960, Biochimica et biophysica acta.
[13] C. McEwen,et al. Comparison of Most Probable Peak Values As Measured for Polymer Distributions by MALDI Mass Spectrometry and by Size Exclusion Chromatography , 1996 .
[14] R. Linhardt,et al. Detection of glycosaminoglycans as a copper(II) complex in high-performance liquid chromatography. , 1997, Journal of chromatography. A.
[15] P. Herrlich,et al. CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.
[16] W. Tew,et al. Relative molecular weight and concentration determination of sodium hyaluronate solutions by gel-exclusion high-performance liquid chromatography. , 1985, Analytical biochemistry.
[17] A. Spicer,et al. Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.
[18] M. Dougados,et al. A HYALURONAN PREPARATION (500–730 KDA) IN THE TREATMENT OF OSTEOARTHRITIS: A REVIEW OF CLINICAL TRIALS WITH HYALGAN® , 2002, International journal of clinical practice.
[19] M. Kinoshita,et al. Hyaluronic acid: separation and biological implications. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[20] B. Reubinoff,et al. Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer medium. , 2003, Fertility and sterility.
[21] R. Jelliffe,et al. In vitro and in vivo studies with sodium hyaluronate as a carrier for intraocular gentamicin , 1991, Acta ophthalmologica.
[22] E. Balazs,et al. Rheology of hyaluronic acid , 1968, Biopolymers.
[23] D J Berry,et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[24] Weiliam Chen,et al. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. , 2004, Biomaterials.
[25] K. Kubota,et al. Effects of sodium chloride, guanidine hydrochloride, and sucrose on the viscoelastic properties of sodium hyaluronate solutions , 1999 .
[26] Robert Gurny,et al. Design and evaluation of controlled release systems for the eye , 1987 .
[27] D. Quaglino,et al. Hyaluronan-phospholipid interactions. , 1997, Journal of structural biology.
[28] D. Jackson,et al. LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.
[29] G. Dutton,et al. Determination of molecular weight of hyaluronic acid in bovine vitreous humour and Healon by high performance gel permeation chromatography and its depolymerization with ascorbic acid. , 1997, Pharmacy world & science : PWS.
[30] A. Ogston,et al. On the state of hyaluronic acid in synovial fluid. , 1950, The Biochemical journal.
[31] D. Monti,et al. Mucoadhesive ophthalmic vehicles: evaluation of polymeric low-viscosity formulations. , 1994, Journal of ocular pharmacology.
[32] N. Volpi. Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. , 2000, Analytical biochemistry.
[33] A. Ogston,et al. The dimensions of the particle of hyaluronic acid complex in synovial fluid. , 1951, The Biochemical journal.
[34] P. Ghosh,et al. Interactions of hyaluronan (hyaluronic acid) with phospholipids as determined by gel permeation chromatography, multi-angle laser-light-scattering photometry and 1H-NMR spectroscopy. , 1994, International journal of biological macromolecules.
[35] A. Trounson,et al. The effect of extracellular matrix molecules on mouse preimplantation embryo development in vitro. , 2002, Reproduction, fertility, and development.
[36] J. Kirwan. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee? , 2001, The Knee.
[37] W. Reed,et al. The effects of pH on hyaluronate as observed by light scattering , 1989, Biopolymers.
[38] B. Pierscionek,et al. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. , 1993, Seminars in arthritis and rheumatism.
[39] C. Cockerell,et al. Actinic Keratoses , 1997 .
[40] Susi Burgalassi,et al. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid , 1989 .
[41] E. Balazs,et al. Viscosupplementation: a new concept in the treatment of osteoarthritis. , 1993, The Journal of rheumatology. Supplement.
[42] R. Schwartz. The Actinic Keratosis A Perspective and Update , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[43] S. Goodison,et al. CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.
[44] K. Anno,et al. Improved method for electrophoretic separation and rapid quantitation of isomeric chondroitin sulfates on cellulose acetate strips. , 1970, Analytical biochemistry.
[45] D. Weinberger,et al. A comparison of the effect of hyaluronic acid versus gentamicin on corneal epithelial healing , 1998, Eye.
[46] J. Harris,et al. Modulation of immunity in cancer patients by prostaglandin antagonists. , 1989, Progress in clinical and biological research.
[47] C. Marriott,et al. The effect of hyaluronan on the in vitro deposition of diclofenac within the skin. , 1995, International journal of tissue reactions.
[48] A. Ogston,et al. Further observations on the preparation and composition of the hyaluronic acid complex of ox synovial fluid. , 1952, The Biochemical journal.
[49] B. Yeung,et al. Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionization mass spectrometry. , 1999, Journal of chromatography. A.
[50] Effect of lyophilization on the physical characteristics of medium molecular mass hyaluronates , 1994 .
[51] M. Hochberg. Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. , 2000, Seminars in arthritis and rheumatism.
[52] G. Prestwich,et al. Hyaluronate derivatives in drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.
[53] L. Lebel. Clearance of hyaluronan from the circulation , 1991 .
[54] M. Davies,et al. Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. , 1996, Free radical biology & medicine.
[55] B. Blumberg. Light-scattering studies on hyaluronic acid. , 1954, Science.
[56] T. Laurent,et al. An early look at macromolecular crowding. , 1995, Biophysical chemistry.
[57] J. Fraser,et al. Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.
[58] G. Phillips,et al. Depolymerization of sodium hyaluronate during freeze drying , 1983 .
[59] Yoshihiro Ohashi,et al. Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue , 1991, Pharmaceutical Research.
[60] J. Scott,et al. Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[61] L. R. Abeydeera. In vitro production of embryos in swine. , 2002, Theriogenology.
[62] G. Martin,et al. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. , 2001, International journal of pharmaceutics.
[63] M. Morishita,et al. Polyion complex of chitosan and sodium hyaluronate as an implant device for insulin delivery , 2003 .
[64] Diego Guidolin,et al. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? , 2002, Seminars in arthritis and rheumatism.
[65] V. Goldberg,et al. Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. , 2003, Orthopedics.
[66] M. Klein,et al. Effects of cryopreservation and deconstruction on the dermal glycosaminoglycan content of human skin. , 1999, Journal of Burn Care and Rehabilitation.
[67] J. Sheehan,et al. Effect of the cations sodium, potassium and calcium on the interaction of hyaluronate chains: a light scattering and viscometric study , 1983 .
[68] D. Ferguson,et al. Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium* , 2001, The Journal of Biological Chemistry.
[69] J. Liu,et al. Thermal Analysis of Semi-Dilute Hyaluronan Solutions , 2000 .
[70] E. Puré,et al. The liberation of CD44 , 2003, The Journal of cell biology.
[71] B. Toole,et al. Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.
[72] S. Feldman,et al. Most common dermatologic problems identified by internists, 1990-1994. , 1998, Archives of internal medicine.
[73] J. Ortonne,et al. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers , 1996 .
[74] J. Raynauld,et al. Intra-articular therapy in osteoarthritis , 2003, Postgraduate medical journal.
[75] E. Suchanek,et al. Follicular fluid contents of hyaluronic acid, follicle-stimulating hormone and steroids relative to the success of in vitro fertilization of human oocytes. , 1994, Fertility and sterility.
[76] John E. Scott,et al. Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. , 2002, Biomacromolecules.
[77] W. Pigman,et al. Interactions of hyaluronic acid with serum albumin. , 1961, Biochimica et biophysica acta.
[78] M. Radice,et al. Semisynthetic resorbable materials from hyaluronan esterification. , 1998, Biomaterials.
[79] R. Herberman,et al. Inhibition of murine natural killer cell activity by prostaglandins. , 1980, Journal of immunology.
[80] M. Tammi,et al. Hyaluronan metabolism in skin. , 1994, Progress in histochemistry and cytochemistry.
[81] H. Greiling,et al. Assay of synovial fluid parameters: hyaluronan concentration as a potential marker for joint diseases. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[82] A. Negi,et al. [Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits]. , 2002, Nippon Ganka Gakkai zasshi.
[83] Kozo Takayama,et al. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[84] Jaroslav Drobník,et al. Hyaluronan in drug delivery , 1991 .
[85] E. Tschen,et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses , 2001, International journal of dermatology.
[86] C. Siebert,et al. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis--a prospective clinical trial. , 2002, Osteoarthritis and cartilage.
[87] W. Pigman,et al. Preparation and stability of hyaluronic acid. , 1961, Biochimica et biophysica acta.
[88] S. Granick,et al. Biolubrication: Hyaluronic Acid and the Influence on Its Interfacial Viscosity of an Antiinflammatory Drug , 2003 .
[89] C. Katakami,et al. The effect of hyaluronic acid on corneal epithelial cell proliferation. , 1993, Investigative ophthalmology & visual science.
[90] J. D. Del Rosso. New and emerging topical approaches for actinic keratoses. , 2003, Cutis.
[91] M. Thibier,et al. Hyaluronic acid as a substitute for proteins in the deep-freezing of embryos from mice and sheep: An in vitro investigation , 1992 .
[92] Weiliam Chen,et al. Characterization of DNA-hyaluronan matrix for sustained gene transfer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[93] D. Peer,et al. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes. , 2000, Archives of biochemistry and biophysics.
[94] T. Hardingham,et al. The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. , 2000, The Biochemical journal.
[95] O. Ishikawa,et al. Hyaluronan exists in the normal stratum corneum. , 2000, The Journal of investigative dermatology.
[96] G. Chow,et al. CD44-mediated uptake and degradation of hyaluronan. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[97] A. Hjerpe,et al. High-performance capillary electrophoretic analysis of hyaluronan in effusions from human malignant mesothelioma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[98] P. Siviero,et al. Retrospective Study of Outcomes in Hyalgan®-Treated Patients with Osteoarthritis of the Knee , 2002, Clinical drug investigation.
[99] T. Nakamura,et al. The effect of sodium hyaluronate on the growth of rabbit corneal epithelial cells in vitro. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[100] P. Band. Hyaluronan Derivatives: Chemistry and Clinical Applications , 1998 .
[101] A. Okamoto,et al. Hydrolytic degradation of hyaluronic acid , 1995 .
[102] G. Karlsson,et al. Determination of the distribution of molecular masses of sodium hyaluronate by high-performance anion-exchange chromatography. , 2003, Journal of chromatography. A.
[103] Graham R. Elliott,et al. Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor , 2004, Cancer Immunology, Immunotherapy.
[104] Tomi Järvinen,et al. Ocular absorption following topical delivery , 1995 .
[105] E. Shimada,et al. Viscosity and molecular weight of hyaluronic acids. , 1975, Journal of biochemistry.
[106] W. Hwang,et al. Effect of glycosaminoglycans on the preimplantation development of embryos derived from in vitro fertilization and somatic cell nuclear transfer. , 2003, Reproduction, fertility, and development.
[107] H. Maibach,et al. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. , 1991, The Journal of investigative dermatology.
[108] M. Tammi,et al. Hyaluronan and Homeostasis: A Balancing Act* , 2002, The Journal of Biological Chemistry.
[109] C. Oner,et al. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis , 2003, Clinical Rheumatology.
[110] I. Koshiishi,et al. Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides. , 1999, Analytical biochemistry.
[111] G. P. Martin,et al. Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies , 1996 .
[112] D. Gardner,et al. Changing the start temperature and cooling rate in a slow-freezing protocol increases human blastocyst viability. , 2003, Fertility and sterility.
[113] G. Phillips,et al. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution. , 2001, Biopolymers.
[114] P. Pasche,et al. Mucosal wound healing after nasal surgery. A controlled clinical trial on the efficacy of hyaluronic acid containing cream. , 1999, Drugs under experimental and clinical research.
[115] R. Margalit,et al. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. , 1998, Archives of biochemistry and biophysics.
[116] D. Monti,et al. Evaluation of high- and low-molecular-weight fractions of sodium hyaluronate and an ionic complex as adjuvants for topical ophthalmic vehicles containing pilocarpine , 1991 .
[117] G. Prestwich,et al. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. , 2000, Biomacromolecules.
[118] Karl Meyer,et al. THE POLYSACCHARIDE OF THE VITREOUS HUMOR , 1934 .
[119] E. Atkins,et al. Structure for hyaluronic acid. , 1972, Nature: New biology.
[120] H. Sasaki,et al. Delivery of drugs to the eye by topical application , 1996, Progress in Retinal and Eye Research.
[121] M. Plätzer,et al. Quantification of hyaluronan in pharmaceutical formulations using high performance capillary electrophoresis and the modified uronic acid carbazole reaction. , 1999, Journal of pharmaceutical and biomedical analysis.
[122] K. Nishinari,et al. Effects of the addition of hyaluronate segments with different chain lengths on the viscoelasticity of hyaluronic acid solutions. , 1996, Biopolymers.
[123] H. Katsumata,et al. Effects of Low-Viscosity Sodium Hyaluronate Preparation on the Pulmonary Absorption of rh-Insulin in Rats , 2001, Drug development and industrial pharmacy.
[124] T BITTER,et al. A modified uronic acid carbazole reaction. , 1962, Analytical biochemistry.
[125] K. Langer,et al. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery: Part III: Evaluation as drug delivery system for ophthalmic applications , 1997 .
[126] H. C. Robinson,et al. The extracellular processing and catabolism of hyaluronan in cultured adult articular cartilage explants. , 1992, Archives of biochemistry and biophysics.
[127] D. Guidolin,et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. , 2001, Osteoarthritis and cartilage.
[128] K. Arnold,et al. Molecular dynamics study of hyaluronic acid in water , 1998 .
[129] K. Lowry,et al. Thermal stability of sodium hyaluronate in aqueous solution. , 1994, Journal of Biomedical Materials Research.
[130] R. Moy. Clinical presentation of actinic keratoses and squamous cell carcinoma. , 2000, Journal of the American Academy of Dermatology.
[131] B. Risberg. Adhesions: preventive strategies. , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.
[132] U. Chakravarthy,et al. Quantitative analysis of hyaluronan in vitreous humor using capillary electrophoresis , 1994, Electrophoresis.
[133] D J Berry,et al. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. , 2002, International journal of pharmaceutics.
[134] R. Wüthrich. The proinflammatory role of hyaluronan-CD44 interactions in renal injury. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[135] K. Nishinari,et al. Viscoelasticity of hyaluronic acid with different molecular weights. , 1994, Biorheology.
[136] O. Fennema,et al. Linear Rate of Water Crystallization as Influenced by Temperature of Hydrocolloid Suspensions , 1987 .
[137] W. Reed,et al. Light scattering power of randomly cut random coils with application to the determination of depolymerization rates , 1989 .
[138] Stefaan De Smedt,et al. HYALURONAN : PREPARATION, STRUCTURE, PROPERTIES, AND APPLICATIONS , 1998 .
[139] D. Gardner,et al. Cryo‐survival and development of bovine blastocysts are enhanced by culture with recombinant albumin and hyaluronan , 2003, Molecular reproduction and development.
[140] G. Turino,et al. Hyaluronan in respiratory injury and repair. , 2003, American journal of respiratory and critical care medicine.
[141] F. Maccari,et al. Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains‐All , 2002, Electrophoresis.
[142] C. Milne. Fetal development. , 1989, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[143] M. Cowman,et al. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. , 1994, Analytical biochemistry.
[144] M. Dougados,et al. Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. , 2000, Seminars in arthritis and rheumatism.
[145] J. Scott. The periphery of the developing collagen fibril. Quantitative relationships with dermatan sulphate and other surface-associated species. , 1984, The Biochemical journal.
[146] T. Miyano,et al. Effects of hyaluronic acid on the development of 1- and 2-cell porcine embryos to the blastocyst stage in vitro. , 1994, Theriogenology.
[147] L. Moreland. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action , 2003, Arthritis research & therapy.
[148] R. Linhardt,et al. Conductivity detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans separated by high-performance size-exclusion chromatography. , 2002, Journal of chromatography. A.
[149] R. Mendichi,et al. Characterization of ultra-high molar mass hyaluronan: 1. Off-line static methods , 1998 .
[150] G. Norstedt,et al. Evaluation of hyaluronan as a vehicle for peptide growth factors , 1992 .
[151] E. Balazs,et al. On the limiting viscosity number of hyaluronate in potassium phosphate buffers between pH 6.5 and 8 , 1983 .
[152] J. Sheehan,et al. Hyaluronan: polysaccharide chaos to protein organisation. , 2001, Current opinion in structural biology.
[153] G. Varigos,et al. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses , 2003, The Australasian journal of dermatology.
[154] G. Turino,et al. Aerosolized Hyaluronic Acid Decreases Alveolar Injury Induced by Human Neutrophil Elastase , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[155] E. Balazs,et al. Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.
[156] B. Delpech,et al. An improved assay for the N-acetyl-D-glucosamine reducing ends of polysaccharides in the presence of proteins. , 2001, Analytical biochemistry.
[157] I. Kellaway,et al. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye , 1995 .
[158] Yuji Inada,et al. Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate , 2004, Glycoconjugate Journal.
[159] K Surendrakumar,et al. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[160] C. Furnus,et al. Effect of hyaluronic acid on development of in vitro produced bovine embryos. , 1998, Theriogenology.
[161] P. Mooar,et al. Intra-articular hyaluronans: a review of product-specific safety profiles. , 2003, Seminars in arthritis and rheumatism.
[162] J. Demeester,et al. Absolute and empirical determination of the enzymatic activity and kinetic investigation of the action of hyaluronidase on hyaluronan using viscosimetry. , 1995, The Biochemical journal.
[163] L. Šoltés,et al. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid , 2002, Inflammation Research.
[164] D. Figgitt,et al. Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel , 2003, American journal of clinical dermatology.
[165] S. Arnott,et al. Hyaluronic acid double helix. , 1983, Journal of molecular biology.
[166] E. Menzel,et al. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. , 1998, Cancer letters.
[167] J. Peyron,et al. A Risk-Benefit Assessment of Injections of Hyaluronan and its Derivatives in the Treatment of Osteoarthritis of the Knee , 2000, Drug safety.
[168] C. Bucolo,et al. Pharmacological Evaluation of a New Timolol/Pilocarpine Formulation , 1998, Ophthalmic Research.
[169] Dan Peer,et al. Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. , 2003, Biochimica et biophysica acta.
[170] W. Panje. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. , 1981, Archives of otolaryngology.
[171] L. Juhlin. Hyaluronan in skin , 1997, Journal of internal medicine.
[172] J. Kreider,et al. Anionic polysaccharide production and tyrosinase activation in cultured human melanoma cells. , 1976, Cancer research.
[173] Shayn E Armstrong,et al. Measurement of high-molecular-weight hyaluronan in solid tissue using agarose gel electrophoresis. , 2002, Analytical biochemistry.
[174] T. Imanari,et al. Sensitive detection of unsaturated disaccharides from chondroitin sulphates by thin-layer chromatography as their dansylhydrazine derivatives. , 1989, Journal of chromatography.
[175] R. Gurny,et al. Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits. , 1987, Current eye research.
[176] H. Rodríguez-Martínez,et al. Effects of sperm treatments on the in vitro development of bovine oocytes in semidefined and defined media. , 1997, Theriogenology.
[177] J. Gergely,et al. Light scattering studies on hyaluronic acid. , 1955, The Journal of biological chemistry.
[178] R. Altman. Intra-articular sodium hyaluronate in osteoarthritis of the knee. , 2000, Seminars in arthritis and rheumatism.
[179] T. Masada,et al. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.
[180] M. How,et al. Separation and fractionation of hyaluronic acid from human synovial fluid on agarose gels. , 1969, Clinica chimica acta; international journal of clinical chemistry.
[181] R. Margalit,et al. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. , 1994, Archives of biochemistry and biophysics.
[182] R. Jelliffe,et al. Sodium hyaluronate as a carrier for intravitreal gentamicin an experimental study , 1991, Acta ophthalmologica.
[183] John L. Wang,et al. Ionic polysaccharides. III. Dilute solution properties of hyaluronic acid fractions , 1970, Biopolymers.
[184] T. Miyano,et al. Effects of glycosaminoglycans on the development of in vitro-matured and -fertilized porcine oocytes to the blastocyst stage in vitro. , 1998, Biology of reproduction.
[185] P. Müller,et al. Specific degradation of hyaluronic acid and its rheological properties , 1998 .
[186] T. Hardingham,et al. The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. , 1999, Biophysical journal.
[187] E. Balazs. Analgesic Effect of Elastoviscous Hyaluronan Solutions and the Treatment of Arthritic Pain , 2003, Cells Tissues Organs.
[188] D. Alcorn,et al. Absorption of hyaluronan applied to the surface of intact skin. , 1999, The Journal of investigative dermatology.
[189] W. Fetter,et al. The influence of contamination of culture medium with hepatitis B virus on the outcome of in vitro fertilization pregnancies. , 1991, American journal of obstetrics and gynecology.
[190] T. Laurent,et al. Catabolism of hyaluronan , 1998 .
[191] D. Gardner,et al. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. , 1999, Human reproduction.
[192] K. Ebert,et al. Ultrasonic degradation of polymers in solution , 1977 .
[193] M. Tammi,et al. Hyaluronan-Cell Interactions in Cancer and Vascular Disease* , 2002, The Journal of Biological Chemistry.
[194] C. Yomota,et al. Hyaluronate depolymerization following thermal decomposition of oxytetracycline. , 2001, Chemical & pharmaceutical bulletin.
[195] H. Melville,et al. The ultrasonic degradation of polymers , 1950 .
[196] A. Okamoto,et al. Degradation of hyaluronic acid during freeze drying , 1997 .
[197] A. Spicer,et al. Mammalian hyaluronan synthases: investigation of functional relationships in vivo. , 1999, Biochemical Society transactions.
[198] G. P. Martin,et al. THE USE OF HYALURONAN IN TOPICAL DRUG DELIVERY , 2002 .
[199] G Mautone,et al. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. , 2002, Drugs under experimental and clinical research.
[200] D. Armstrong,et al. Outcomes of hyaluronan therapy in diabetic foot wounds. , 2003, Diabetes research and clinical practice.
[201] E. Balazs,et al. Drug delivery systems using hyaluronan and its derivatives , 1991 .
[202] C. Balch,et al. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. , 1982, Surgery.
[203] R. Gurny,et al. Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[204] R. Herrero-Vanrell,et al. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[205] I. Kaur,et al. Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery , 2002, Drug development and industrial pharmacy.
[206] F. Szoka,et al. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. , 2001, Cancer research.
[207] G. Prestwich,et al. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. , 1999, Bioconjugate chemistry.